Purpose: Advanced head and neck cancer shows hypoxia that results in biological changes
to make the tumor cells more aggressive and less responsive to treatment resulting in poor …

18 F-FDG PET images of tumors often display highly heterogeneous spatial distribution of 18
F-FDG–positive pixels. We proposed that this heterogeneity in 18 F-FDG spatial distribution …

… O'Sullivan & Hilliard's The Law of Contract provides students with a clear, straightforward, …
updated by Cambridge academic and teacher, Janet O'Sullivan. All the key topics on the LLB …

HER-2/neu is a growth factor receptor, the expression of which has been associated with a
more aggressive breast tumor biology and resistance to some types of chemotherapy. …

PURPOSE To test the hypothesis that high bcl-2 expression and accumulation of p53 protein,
both of which should inhibit apoptosis, are associated with a poorer tamoxifen response …

PURPOSE: Factorial designs may be proposed to test extra questions within a clinical trial.
A common approach to sample size and analysis for factorial trials assumes no statistical …

Synovial sarcoma generally is associated with poor prognosis. With recent advances in
molecular biology, it has become apparent not all synovial sarcomas share the same tumor …

Assessing therapy response of breast cancer bone metastases is challenging. In retrospective
studies, serial 18 F-FDG PET was predictive of time to skeletal-related events (tSRE) and …

An automated procedure including both in-line preconcentration and multi-element determination
by an inductively coupled plasma mass spectrometer (ICP-MS) has been developed …

18 F-fluoromisonidazole ( 18 F-FMISO) is the most widely used PET agent for imaging
hypoxia, a condition associated with resistance to tumor therapy. F-FMISO equilibrates in …